Lawrence L Horstmann

Title: Innovations in Hemostasis: The Contributions of Lawrence L Horstmann

Introduction

Lawrence L Horstmann is an accomplished inventor based in Miami, FL (US). He has made significant contributions to the field of hemostasis through his innovative research and patenting efforts. His work focuses on developing solutions for controlling hemorrhage and treating bleeding disorders.

Latest Patents

Horstmann holds a patent for "Cell-derived microparticles as hemostatic agents for control of hemorrhage and treatment of bleeding disorders." This patent describes compositions comprising membrane-derived and synthetic microparticles that induce platelet aggregation. These microparticles are particularly useful for treating bleeding disorders, especially those involving platelet dysfunction. The microparticles include endothelial-derived microparticles (EMP), platelet-derived microparticles (PMP), erythrocyte-derived microparticles (RMP), and synthetic microparticles (SMP). They are designed to treat disorders such as thrombocytopenia caused by chemotherapy.

Career Highlights

Horstmann is affiliated with the University of Miami, where he continues to advance his research in the field of hemostasis. His work has garnered attention for its potential to improve treatment options for patients suffering from bleeding disorders.

Collaborations

Some of his notable coworkers include Wenche Jy and Joaquin J Jimenez, who have collaborated with him on various research projects.

Conclusion

Lawrence L Horstmann's innovative work in developing microparticle-based therapies represents a significant advancement in the treatment of bleeding disorders. His contributions are paving the way for new therapeutic options that could greatly benefit patients in need.